58602-832Level 3
Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache (Naproxen Sodium and Pseudoephedrine Hydrochloride)
**Product type:** Human Otc Drug
**Active ingredient:** NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
**Strength:** 220; 120 mg/1; mg/1
**Dosage form:** Tablet, Extended Release
**Route:** Oral
**Labeler:** Aurohealth LLC
**Marketing category:** ANDA (ANDA211360)
**Pharmacologic class:** Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/58602-832Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.